A Randomized, Phase 3 Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Previously Treated Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Sunitinib (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 11 Aug 2017 This trial has been Discontinued in Belgium, according to European Clinical Trials Database.
- 15 Jul 2013 Results published in the Journal of Clinical Oncology.
- 01 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History